SeaSpine
Global medical technology company designing and commercializing spinal surgery solutions, including 3D-printed interbody implants, orthobiologics, and surgical navigation systems.
- CEO / Founder
- Keith C. Valentine
- Team Size
- 501-1000
- Stage
- Acquired
- Latest Round
- Acquired
Technology & Products
Key Products
Spinal implant systems (e.g., Meridian ALIF, Reef interbodies); Orthobiologics; 7D FLASH Surgical Navigation System
Technological Advantage
SeaSpine used additive manufacturing for interbody fusion devices, complementing its existing spine portfolio. AM is not the core business but enables differentiated implant geometries. Limited patent protection; company held 3 patents issued in FY2016 (per Craft).
Differentiation
Value Proposition
Offers an integrated portfolio of spinal implants, biologics, and navigation, with 3D-printed interbody devices aimed at improving fusion and surgical outcomes.
How They Differentiate
SeaSpine differentiates by offering a comprehensive spine portfolio (implants + biologics + navigation) rather than focusing solely on 3D-printed devices; its 3D-printed interbodies are part of a broader surgical solution.
Market & Competition
Target Customers
Spine surgeons, hospitals, and healthcare providers
Industry Verticals
Medical devices; Spine surgery
Competitors
4WEB Medical; NuVasive; Stryker
Growth & Milestones
Growth Metrics
Revenue of $191M in 2021, up 24% YoY; acquired by Orthofix in January 2023.
Major Milestones
Incorporated in 2015 via spin-off from Integra LifeSciences; Listed on NASDAQ as SPNE; Acquired 7D Surgical for ~$110M in 2021; Launched first 3D-printed interbody devices in 2021; Merged with Orthofix Medical in January 2023
Funding rounds
- IPO2015-08Source: Web